NCT07121959View on ClinicalTrials.gov

A Study of Belzutifan (MK-6482) and Metformin in Healthy Adult Participants (MK-6482-039)

PHASE1CompletedINTERVENTIONAL

Enrollment

14

Participants

Timeline

Start Date

August 18, 2025

Primary Completion Date

September 13, 2025

Study Completion Date

September 26, 2025

Conditions

Healthy

Interventions

DRUG

Metformin

Oral Tablet

DRUG

Belzutifan

Oral Tablet

Trial Locations (1)

85283

Celerion ( Site 0001), Tempe

All Listed Sponsors

lead

Merck Sharp & Dohme LLC

INDUSTRY